Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Study Identifier
M10-385
CT.gov Identifier
NCT00761150
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Pain
    • Study Drug
  • ABT-712
  • Placebo
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    21 - 75 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Adult male and female subjects who voluntarily sign the informed consent * Diagnosis of CLBP of 6 months duration
    Exclusion Criteria:
    * Incapacitated or bedridden subjects * Subjects with history of surgical or invasive intervention

    Protocol Summary

    The primary purpose of the study was to test the efficacy of 2 tablets (twice daily) of ABT-712, compared to placebo, administered over a 4-week period in participants with moderate to severe mechanical chronic low back pain (CLBP).

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 10143
    Tempe, Arizona, United States, 85282
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10161
    Tempe, Arizona, United States, 85282
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10155
    Tucson, Arizona, United States, 85741
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10160
    Anaheim, California, United States, 92801
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10821
    Lomita, California, United States, 90717
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 10152
    Clearwater, Florida, United States, 33765
    Status
    Not applicable
    Showing {first} - {last} of {total} Results